Moderna CEO Is 'Cautiously Optimistic' About Covid-19 Vaccine by Next Year

The speaker expresses cautious optimism about the development of a COVID-19 vaccine, highlighting the commitment of companies and the exemplary partnership with government agencies. The collaboration is strong, with frequent communication and a shared goal. The speaker emphasizes the need for multiple vaccines to meet global demand, as no single company can fulfill the world's needs alone.

What is the speaker's outlook on the development of a COVID-19 vaccine?

• Pessimistic

• Cautiously optimistic

• Uncertain

• Indifferent

Which government agency is mentioned as part of the collaboration for vaccine development?

• NIH

• CDC

• FDA

• WHO

How often do the companies communicate with the government agencies?

• Once a month

• Two or three times per day

• Once a day

• Once a week

Why does the speaker hope for more than one vaccine to succeed?

• To meet global demand

• To increase competition

• To reduce costs

• To improve vaccine quality

What is the main reason no single company can meet the world's vaccine needs?

• Limited research capabilities

• High production costs

• Lack of technology

• Insufficient production capacity